CEO of Relmada Therapeutics, Inc. (NASDAQ:RLMD), Traversa Sergio, sells 1,930 shares worth $68,097
According to Relmada Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Feb 10 07:25 PM, company CEO, Traversa Sergio disclosed selling 1,930 shares at a cost of $35.28. At the time of this transaction (Feb 10), this trade was worth $68,097 in total. As of Feb 10, Traversa Sergio now owns 88,774 shares in total worth about $3,102,651.3000000003.
For the last few recent trades made by Relmada Therapeutics, Inc. (NASDAQ:RLMD) CEO, Traversa Sergio, we have the following information:
- SEC Form 4 filing: Feb 08: Sold 3,313 shares at the rate of $35.03 per share. Total worth of this trade was $116,049. Total number of shares owned as of Feb 08 were 96,667
- SEC Form 4 filing: Feb 09: Sold 5,963 shares at the rate of $35.21 per share. Total worth of this trade was $209,939. Total number of shares owned as of Feb 09 were 90,704
- SEC Form 4 filing: Feb 02: Sold 3,178 shares at the rate of $35.08 per share. Total worth of this trade was $111,470. Total number of shares owned as of Feb 02 were 88,874
Posted by
George Daniels
on Wednesday February 10 2021, 10:53 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
